AzTrials
AzTrials

Preterm BirthCRAFTNCT04110704

Cerclage After Full Dilatation Caesarean Section

A study testing Insertion of transvaginal cerclage in people with Preterm Birth and Preterm Premature Rupture of Membrane, run by Guy's and St Thomas' NHS Foundation Trust at 1 site in United Kingdom.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

CRAFT-OBS: Observational Study; To evaluate subsequent pregnancy risk of preterm birth in women with a history of previous caesarean in established labour. This prospective study using clinically acquired cervical length and quantitative fetal fibronectin data will help establish a predictive model of preterm birth… Read more about this study

Who is it for?
Ages 16 years and older, women onlyHealthy volunteers can take part
What is being tested?
Insertion of transvaginal cerclage
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,000 participants
Where
1 siteUnited Kingdom
Study dates
2 Oct 2019to 1 Oct 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • Women only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Pregnant women under 23+6 weeks gestation with a history of previous caesarean section in labour.
  • Singleton pregnancy.
  • Willing and able to give informed consent (with or without interpreter).
  • Pregnant women up to 23+6 weeks gestation with a history of FDCS.
  • Short cervix (<=25mm) on transvaginal ultrasound scan.
  • Pregnant women between 14+0 and 23+6 weeks gestation with a history of FDCS.

Who cannot join

  • Under 16 years of age.
  • Inability to give informed consent.
  • Previous caesarean section carried out before labour.
  • Women who have been commenced on management with progesterone, a cerclage or arabin pessary as part of their care or another research study
  • CRAFT-RCT:
  • Women with persistent fresh vaginal bleeding evident on speculum examination.
Show all 12Show fewer
  • Women with visible fetal membranes evident on speculum examination or open cervix on ultrasound scan.
  • Women with severe abdominal pain/evidence of sepsis (as judged by attending clinician).
  • Known significant congenital or structural or chromosomal fetal abnormality.
  • Suspected or proven rupture of the fetal membranes at the time of recruitment.
  • CRAFT-IMG
  • Contraindications to MRI, e.g. claustrophobia, BMI >40 kg/m2 (due to technical limitations of scanner) or a women with a non-MRI compatible metallic implant.

Trial locations and contacts

1 site in 1 country.

Michael Waring contact

michael.waring@kcl.ac.uk

United Kingdom1 site, 1 recruiting
  • Guy's and St Thomas' Hospital NHS Foundation Trust

    London, SE1 7EH

    Agnieszka Glazewska-Hallin

    Recruiting

Other trials in United Kingdom

About this study

Official title: An Investigation Into the Role of Previous in Labour Caesarean Section in Future Preterm Birth Risk and Management Strategies

CRAFT-OBS: Observational Study; To evaluate subsequent pregnancy risk of preterm birth in women with a history of previous caesarean in established labour. This prospective study using clinically acquired cervical length and quantitative fetal fibronectin data will help establish a predictive model of preterm birth <34 weeks and <37 weeks.

CRAFT-RCT: Randomised controlled trial arm; To assess treatment for short cervix in women at high risk of preterm birth following a caesarean section at full dilatation

CRAFT-IMG: Imaging sub-study; To aid understanding of micro and macrostructural features within the cervix which predisposes to preterm birth in women with a previous full dilatation caesarean section. This will use MRI and an advanced transvaginal ultrasound protocol and to assess if structural changes can be visualised in the cervix.

Being tested
Insertion of transvaginal cerclage
Medical subject headings
Premature Birth, Preterm Premature Rupture of the Membranes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Insertion of transvaginal cerclageProcedure or surgery

    Transvaginal cerclage is inserted in women with a high risk of preterm birth. However it is unknown whether this alongside cervical length monitoring improves the incidence of preterm birth. The cerclage is inserted under regional analgesia.

Study groups in NCT04110704
Study groupRoleWhat they receive
Transvaginal cerclageActive comparatorNot described
Receives: Procedure: Insertion of transvaginal cerclage
Active monitoringNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. CRAFT-OBS: Number of participants with spontaneous preterm birth rate < 37 weeks gestation

    Measured: Up to 42 weeks

  2. CRAFT-RCT: Number of participants with spontaneous preterm birth <34 weeks gestation

    Measured: Up to 42 weeks

Secondary outcomes (18)
  1. CRAFT-OBS: Short-term pregnancy and neonatal outcomes, including a composite of neonatal death and morbidity.

    We will assess the number of antepartum/intrapartum stillbirths plus neonatal deaths prior to discharge from neonatal services.

    Measured: Up to 48 weeks

  2. CRAFT-OBS: Number of participants with adverse perinatal outcome, defined as a composite outcome of death (antepartum/intrapartum stillbirths plus neonatal deaths prior to discharge from neonatal services)

    Measured: Up to 48 weeks

  3. CRAFT-OBS: Number of participants who deliver <34 weeks gestation

    Measured: Up to 42 weeks

  4. CRAFT-OBS: Gestation at delivery

    The proportion of participants who delivery at each gestation of completed weeks

    Measured: Up to 42 weeks

  5. CRAFT-OBS: Late miscarriage (14+0-23+6 weeks) rate

    Measured: Up to 42 weeks

  6. CRAFT-OBS: Any cervical length measurements taken antenatally

    Measured: Up to 42 weeks

  7. CRAFT-OBS: Number of antenatal hospital appointments

    Measured: Up to 42 weeks

  8. CRAFT-OBS: Number of hospital admissions

    Measured: Up to 42 weeks

  9. CRAFT-OBS: cervicovaginal fetal fibronectin protein levels taken at any gestation if taken

    Measured: Up to 42 weeks

  10. CRAFT-OBS: Number of ultrasound indicated antenatal interventions

    Measured: Up to 42 weeks

  11. CRAFT-OBS: Predictive modelling (QUIPP app) to evaluate the ability of CL and fFN to determine risk of preterm birth <34 and <37 weeks

    Measured: Up to 42 weeks

  12. CRAFT-OBS: Number of participants with other maternal and fetal morbidities, as per COPOP core outcome set for preterm birth intervention studies

    COPOP core outcomes

    Measured: Up to 48 weeks

  13. CRAFT-RCT: Number of participants with an adverse perinatal outcome

    Measured: Up to 48 weeks

  14. CRAFT-RCT: Gestation at delivery

    Proportion of participants who deliver at each gestation of completed weeks

    Measured: Up to 42 weeks

  15. CRAFT-RCT: Number of women needing insertion of a rescue cerclage (done when membranes exposed or bulging)

    Measured: Up to 30 weeks

  16. CRAFT-RCT: Time between intervention and delivery.

    Measured: Up to 42 weeks

  17. CRAFT-RCT - Health costs at 28 days post-delivery.

    Measured: Up to 48 weeks

  18. CRAFT-IMG: Evidence of cervical injury

    Size of any cervical lesion and its location seen on MRI or ultrasound scans

    Measured: Up to 40 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Oct 2019
  2. Study start2 Oct 2019
  3. Primary completion1 Apr 2022 (estimated)
  4. Study completion1 Oct 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
1,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04110704
Sponsor's protocol ID
261294
Other IDs
42833
Acronym
CRAFT
Status last verified
Jul 2021
First submitted
26 Sep 2019
Last updated
28 Jul 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Insertion of transvaginal cerclage in people with Preterm Birth and Preterm Premature Rupture of Membrane, run by Guy's and St Thomas' NHS Foundation Trust at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 28 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Agnieszka Glazewska-Hallin (020 7188 ext. 8151, agnieszka.glazewska-hallin@kcl.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

CRAFT-OBS: Number of participants with spontaneous preterm birth rate < 37 weeks gestation (time frame: Up to 42 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Cerclage After Full Dilatation Caesarean Section | AzTrials